Reproductive and Developmental Medicine Impact Factor, Indexing, Ranking 2024

Reproductive and Developmental Medicine (RDM) is an international peer-reviewed journal, sponsored by the Chinese Medical Association, Obstetrics and Gynecology Hospital of Fudan University, Shanghai Institute for Biomedical and Pharmaceutical Technologies. It is in collaboration with the Wolters Kluwer Health international academic publishing house.The journal is being published in quarterly basis, and aims to publish high quality scientific articles in the field of reproductive medicine and developmental biology, including original research (basic, clinical and translational), reviews, opinions and debates on current importance or controversy of reproductive medicine and developmental biology.Studies in the following areas, but not limited to, will be considered: reproductive endocrinology, reproductive immunology, gametogenesis, fertilization, embryo development and implantation, birth defect, reproductive genetics, biology of reproduction, fertility preservation, andrology, genetic diagnosis, preimplantation genetic testing, germline stem cell research, and new techniques and methods in reproductive medicine and developmental biology. Research that would be classified as clearly in the fields of reproductive system oncology will not normally be published.

《生殖与发育医学》（Reproductive and Developmental Medicine，简称 RDM）是一本由中华医学会、复旦大学附属妇产科医院及上海生物医学与制药技术研究所共同赞助的国际同行评审期刊。该期刊与沃尔特斯克卢维尔健康国际学术出版社协作出版。期刊以季刊形式发行，致力于发表生殖医学和发育生物学领域的高质量科学论文，涵盖原创研究（基础、临床和转化）、综述、关于生殖医学和发育生物学当前重要性和争议性的观点与辩论。考虑纳入的研究领域包括但不限于生殖内分泌学、生殖免疫学、配子发生、受精、胚胎发育和着床、出生缺陷、生殖遗传学、生殖生物学、生育力保存、男性学、遗传诊断、胚胎植入前遗传检测、生殖系干细胞研究以及生殖医学和发育生物学领域的新技术和方法。明显属于生殖系统肿瘤学领域的研究通常不会被发表。